Rossmore Private Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.8M | Buy |
46,722
+525
| +1% | +$113K | 0.95% | 26 |
|
|
2026
Q1 | $10M | Sell |
46,197
-68
| -0.1% | -$15.1K | 0.88% | 28 |
|
|
2025
Q4 | $10.6M | Buy |
46,265
+4,593
| +11% | +$1.05M | 0.94% | 27 |
|
|
2025
Q3 | $9.65M | Buy |
41,672
+55
| +0.1% | +$11.2K | 1.04% | 24 |
|
|
2025
Q2 | $7.73M | Sell |
41,617
-86
| -0.2% | -$16K | 0.9% | 27 |
|
|
2025
Q1 | $8.74M | Sell |
41,703
-683
| -2% | -$133K | 1.08% | 22 |
|
|
2024
Q4 | $7.53M | Sell |
42,386
-543
| -1% | -$99.8K | 0.93% | 27 |
|
|
2024
Q3 | $8.48M | Buy |
42,929
+999
| +2% | +$186K | 1.05% | 23 |
|
|
2024
Q2 | $7.19M | Sell |
41,930
-574
| -1% | -$95.1K | 0.94% | 26 |
|
|
2024
Q1 | $7.74M | Sell |
42,504
-383
| -0.9% | -$66K | 1.01% | 25 |
|
|
2023
Q4 | $6.65M | Hold |
42,887
| – | – | 0.94% | 28 |
|
|
2023
Q3 | $6.39M | Buy |
42,887
+64
| +0.1% | +$9.39K | 0.97% | 27 |
|
|
2023
Q2 | $5.77M | Buy |
42,823
+1,876
| +5% | +$275K | 0.86% | 30 |
|
|
2023
Q1 | $6.53M | Buy |
40,947
+104
| +0.3% | +$15.9K | 1.02% | 28 |
|
|
2022
Q4 | $6.6M | Buy |
40,843
+160
| +0.4% | +$24.5K | 1.06% | 26 |
|
|
2022
Q3 | $5.46M | Buy |
40,683
+1,262
| +3% | +$181K | 0.98% | 29 |
|
|
2022
Q2 | $6.04M | Buy |
39,421
+1,097
| +3% | +$168K | 1.05% | 24 |
|
|
2022
Q1 | $6.21M | Buy |
38,324
+2,716
| +8% | +$395K | 0.97% | 23 |
|
|
2021
Q4 | $4.82M | Buy |
35,608
+4
| +0% | +$473 | 0.75% | 34 |
|
|
2021
Q3 | $3.84M | Buy |
35,604
+84
| +0.2% | +$9.6K | 0.66% | 41 |
|
|
2021
Q2 | $4M | Buy |
35,520
+849
| +2% | +$95.6K | 0.68% | 39 |
|
|
2021
Q1 | $3.75M | Sell |
34,671
-1,218
| -3% | -$130K | 0.7% | 39 |
|
|
2020
Q4 | $3.85M | Buy |
35,889
+2,197
| +7% | +$211K | 0.78% | 37 |
|
|
2020
Q3 | $2.95M | Buy |
33,692
+400
| +1% | +$37.7K | 0.69% | 41 |
|
|
2020
Q2 | $3.27M | Buy |
33,292
+2,931
| +10% | +$258K | 0.9% | 29 |
|
|
2020
Q1 | $2.31M | Buy |
30,361
+4,187
| +16% | +$357K | 0.8% | 40 |
|
|
2019
Q4 | $2.32M | Buy |
26,174
+5,525
| +27% | +$459K | 0.71% | 34 |
|
|
2019
Q3 | $1.56M | Hold |
20,649
| – | – | 0.53% | 44 |
|
|
2019
Q2 | $1.5M | Buy |
20,649
+5,525
| +37% | +$434K | 0.53% | 38 |
|
|
2019
Q1 | $1.22M | Sell |
15,124
-485
| -3% | -$39.7K | 0.45% | 44 |
|
|
2018
Q4 | $1.44M | Buy |
15,609
+400
| +3% | +$35.2K | 0.61% | 32 |
|
|
2018
Q3 | $1.44M | Buy |
15,209
+6,910
| +83% | +$655K | 0.58% | 35 |
|
|
2018
Q2 | $769K | Buy |
8,299
+1,288
| +18% | +$126K | 0.5% | 44 |
|
|
2018
Q1 | $664K | Buy |
7,011
+2,012
| +40% | +$221K | 0.67% | 37 |
|
|
2017
Q4 | $483K | Buy |
+4,999
| New | +$471K | 0.49% | 46 |
|
Other funds holding ABBV
Rossmore Private Capital's ABBV Position: Q2 2026 in Review
Rossmore Private Capital increased its AbbVie (ABBV) stake by 1.1% in Q2 2026, buying an estimated $113K and bringing the position to 46,722 shares worth $11.8M. The position accounts for 0.95% of the portfolio, ranked #26.
Rossmore Private Capital first reported a position in ABBV in Q4 2017 and has held it in 35 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Rossmore Private Capital held 46,722 shares of AbbVie worth $11.8M as of Q2 2026.
- Rossmore Private Capital bought 525 AbbVie shares in Q2 2026, an estimated $113K.
- AbbVie made up 0.95% of Rossmore Private Capital's portfolio in Q2 2026, its #26 holding.
- Rossmore Private Capital first reported a position in AbbVie in Q4 2017 and has held it in 35 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Rossmore Private Capital's 13F filing for Q2 2026, filed 31 Jul 2026.